Studies Umckaloabo effective against respiratory infections
Now scientists have looked more closely at the effect of a special root extract (Pelargonium special extract EPs® 7630) on its effect on respiratory diseases. They included 13 studies in their meta-analysis. The study populations were of different ages and suffered from either acute bronchitis, sinusitis or tonsillopharyngitis. The studies were all double-blinded and tested the Pelargonium special extract EPs® 7630 (Umckaloabo®) against placebo.
Patients with acute bronchitis benefited much more strongly with verum than with placebo: 20% of the patients were symptom-free with plant extract on the seventh day, compared to only 5% with placebo. At the time, 84% of the verum group were able to work, compared to 51% of the placebo group.
Patients with rhinosinusitis also benefited from Pelargonium extract therapy. The headache had completely disappeared on the seventh day in 17%, on placebo only in 3%.
Sufferers with throat infections were already 40% symptom-free with administration on the fourth day and 28% on placebo. The dysphagia on day 4 had disappeared in 57% of the patients, and in 28% with placebo administration. The study can be found here. (Pm)